CFA/IASLC Translational Thoracic Oncology Research Grants

CFA/IASLC Translational Thoracic Oncology Research Grants

Due Date: 01/08/2026

Early-career translational clinical-oncology grants to advance lung cancer detection, diagnostics, therapy selection, side-effect minimization, outcomes, and access—prioritizing projects with near-term patient impact and benefits for underrepresented populations.

Eligibility Criteria:

  • IASLC member; doctoral degree (MD, DO, PhD, PharmD, ScD or equivalent).

  • Instructor/Assistant/Associate Professor (or equivalent); full professors ineligible.

  • Within 7 years of residency/fellowship (physicians) or postdoc (lab scientists); limited exceptions possible.

  • No prior LCFA grant; not PI on R01/DOD-equivalent or ≥125,000 USD/year ×3 years peer-reviewed awards (mentored K/CDAs allowed).

  • Institutional commitment ~50% effort for the applicant.

Funding Details:

  • 100,000 USD per year for up to 2 years (year 2 contingent on satisfactory progress and funds availability).

  • ≤50% of budget for salary/benefits; no indirects; no permanent equipment; travel capped at 1,000 USD/year.

Deadline:

  • Application Deadline: January 8, 2026.

  • Applicants Notified: By May 15, 2026.

Where To Go For Further Information: